Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Uterine Neoplasms

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Uterine Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bae, DS; Keserci, B; Kim, BG; Kim, JH; Kim, TJ; Kim, YS; Köhler, MO; Lee, JH; Lee, JW; Lim, HK; Park, BK; Rhim, H; Sokka, S1

Trials

1 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Uterine Neoplasms

ArticleYear
Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids.
    Investigative radiology, 2011, Volume: 46, Issue:10

    Topics: Adult; Contrast Media; Female; Heterocyclic Compounds; High-Intensity Focused Ultrasound Ablation; Humans; Least-Squares Analysis; Leiomyoma; Linear Models; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Interventional; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Treatment Outcome; Uterine Neoplasms

2011